PARTNER

PARTNERS

Altea Pharma is seeking strategic partners for in- and out-licensing as well as for joint product development within both pharmaceuticals (pharma) and medical technology (medtech). We work actively to identify products and technologies that can create added value for patients and healthcare in the Nordics, while also offering opportunities for partners to establish or expand their presence in the region.

As part of our offering, we also develop our own dossiers and development projects, and we welcome collaborations that can strengthen our innovations and contribute to faster market access. Through our experience in regulatory processes, commercialisation and market access in the Nordics, we can create efficient and successful partnerships.

Whether it concerns the introduction of new medicines, improved formulations or innovative medical technology solutions, we work towards long-term, value-creating collaborations with a focus on quality, patient benefit and growth.

DISTRIBUTION

Altea Pharma offers strategic distribution solutions for pharmaceuticals and medical technology products in the Nordics. As a Nordic partner, we are responsible for market launch, distribution and commercialisation, ensuring an efficient route to market.

With a deep understanding of regulatory requirements, market access and supply chain management, we enable rapid and sustainable establishment in the region. Through our network and local expertise in RX, OTC and medtech, we create value for partners seeking a reliable player for distribution and sales in the Nordics.

IN-LICENSING

Altea Pharma is seeking partners for in-licensing of medicines, including both generics and Value Added Medicines, with the potential to create value in the Nordic market. We identify and evaluate products where improved availability, differentiation or patient benefit can be realised through our local expertise.

As a Nordic partner, we are responsible for the entire value chain, from regulatory processes and market access to distribution and commercialisation. With solid experience in introducing both generic medicines and enhanced products, we ensure efficient establishment and long-term growth in the Nordics.

DOSSIER, ACQUISITION OR DEVELOPMENT

Altea Pharma offers partnerships in the acquisition and development of pharmaceutical dossiers, with a focus on creating value-generating products for the Nordic market. We are interested in acquiring completed dossiers as well as entering into collaborations for the joint development of new dossiers within both generics and Value Added Medicines.

We work closely with our partners throughout the entire process, from development and registration to commercialisation. With a flexible, partner-driven model, Altea Pharma creates opportunities to maximise the value of pharmaceutical projects and accelerate access to new treatment options in the Nordics.